Avicenna Biosciences Revenue

Biotechnology Research • Durham, North Carolina, United States • 11-20 Employees

Avicenna Biosciences revenue & valuation

Annual revenue	$1,026,660
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,300,000
Total funding	$15,000,000

Key Contact at Avicenna Biosciences

Pieter Burger

Co-Founder And Vice President Of Informatics

Company overview

Headquarters	101 W Chapel Hill St, Durham, North Carolina 27701, US
Website	avicenna-bio.com
NAICS	541714
Keywords	Biotechnology, Drug Discovery, Drug Development, Artificial Intelligence, Machine Learning, Lead Optimization, Medicinal Chemistry, Small Molecules, FEP
Founded	2020
Employees	11-20
Socials

Avicenna Biosciences Email Formats

Avicenna Biosciences uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@avicenna-bio.com), used 50% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@avicenna-bio.com	50%
{first name}{last name}	johndoe@avicenna-bio.com	50%

About Avicenna Biosciences

Avicenna Biosciences was founded to solve the intractable challenges that previously stopped drug candidates in their tracks. We have created an ML-driven medicinal chemistry platform that makes Lead Optimization faster, cheaper, and more successful – transforming sub-optimal development candidates into life-saving drugs. The platform has seen rapid success in discovering the first orally available, CNS-penetrant ROCK inhibitors for the treatment of neurodegenerative diseases, with IND-enabling studies initiated just one year since the program kicked off.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

C-Suite

Senior

Employees by Department

Avicenna Biosciences has 8 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Avicenna Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-01-30	1	$3,000,000
2024-03-23	12	$12,000,000

Funding Insights

$15,000,000

Total funding amount

$12,000,000

Most recent funding amount

Number of funding rounds

Avicenna Biosciences Tech Stack

Discover the technologies and tools that power Avicenna Biosciences's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Next.js

JavaScript frameworks

Contentful

CMS

Node.js

Programming languages

HSTS

Security

Open Graph

Miscellaneous

GSAP

JavaScript frameworks

React

JavaScript frameworks

Webpack

Miscellaneous

Vercel

PaaS

Priority Hints

Performance

Frequently asked questions

Avicenna Biosciences is located in Durham, North Carolina, US.

Avicenna Biosciences generates an estimated annual revenue of $1,026,660. This revenue figure reflects the company's market position and business performance in its industry.

Avicenna Biosciences has an estimated valuation of $3,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Avicenna Biosciences was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Avicenna Biosciences has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Avicenna Biosciences has raised a total of $15,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Avicenna Biosciences

Pieter Burger

Co-Founder And Vice President Of Informatics

4.8

40,000 users